Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This document (Policy A59564) is a response to public comments on the proposed policy 'Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound' and records the comment period (6/15/2023–7/29/2023) and the open meeting on 7/13/2023. It does not itself establish coverage criteria, limitations, documentation requirements, or frequency limits for services. For actionable coverage criteria, consult the originating proposed or finalized policy documents.